Опубликовать статью

Информационное партнерство

Инфоресурсы

Контакты

«

Vol. 12, Art. 69 (pp. 817-824)    |    2011       

»

Quality of life of patients with multiple myeloma related to the primary disease duration

Sakhapova G.F.*, Gerasimova L.P., Kabirova M.F., Yanturina N.Kh.**

Bashkirian State Medical University, Ufa
* Bonitet Joint Stock Company, Ufa
** City Clinical Hospital N 13

Brief summary

We have conducted a study on quality of life of 68 patients with multiple myeloma using the EORTC QLQ-C30 questionnaire and its module Myeloma MY20. Depending on the primary disease duration we identified three groups: Group I (less than 1 year) – 26 subjects, Group II (from 1 to 3 years) – 28 subjects, Group III (more than 3 years) – 14 subjects. The questionnaire survey has shown the relationship between patients’ quality of life and the primary disease duration. In addition to this, diverse components of ill health have been identified in different groups. This should be taken into account while planning and correcting medical preventive measures.


Key words

качество жизни, множественная миелома, опросник EORTC QLQ - C30, модуль Миелома MY20.

Reference list

1. Varshavskii A.V. , Bakirov B.A. Dinamika zabolevaemosti gemoblastozami v Respyblike Bashkortostan (1999-2008 gg.) // Medicinskii vestnik Bashkortostana. – 2010. - №3. – S. 12-15.


2. Kalimyllina D.H., Bakirov A.B., Viktorova T.V. Mnojestvennaya mieloma: kliniko-geneticheskie aspekti /Yfa: Gilem, 2004, 120 s.


3. Novickii A.V., Syhonos U.A., Petlenko S.V. Prognosticheskoe znachenie obshego kachestva jizni y bolnih zlokachestvennimi limfomami // www/ medline.ru Tom 10. Onkologiya, Oktyabr, 2009.


4. Rychkin V.N., Bakirov A.B., Kalimyllina D.X. Zabolevaemost i smertnost ot mnojestvennoi mielomi v Respyblike Bashkortostan // Rossiiskii onkologicheskii jyrnal. - 2004.-N 4.-S.40-41


5. Alexanian R., Dimopoulos M.A. Hester I., et al. Early myeloablative therapy for multiple myeloma// Blood. – 1994. – Vol. 84. – P. 4278 – 4282.


6. Aaronson N.K., Cull A., Kaasa S., Sprangers M. The European Organisation for Research and Treatment of Cancer (EORTC) Modular Approach to Quality of Life Assessment in Oncology // Int.J.Ment.Health. - 1994. N 23.-P.75-96.


7. Aaronson N.K. Methodologic issues in assessing the quality of life of cancer patients // Cancer. – 1991. – Vol.67. - №3. – P.844-950.


8. Fayers P., Aaronson N., Bjordal K., Sullivan M. EORTC QLQ-C30 scoring manual. EORTC Study Group on Quality of Life, Brussels, - 1995 - P. 50.


9. Hjermstad M.J., Fossa S.D., Bjordal K., Kaasa S. Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. // J Clin Oncol. - 1995. - May, N.13(5). - P.1249-1254.


10. Kaasa S., Bjordal K., Aaronson N., Moum T., Wist E., Hagen S., Kvikstad A. The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy. // Eur J Cancer. - 1995. Dec. - Vol. 31A, N.13-14. - P.2260-3.


11. Therasse P. A practical guide to EORTC (European Organization for Research and Treatment of Cancer) studies. EORTC Data Center, Brussels, - 1996.